|Bid||4.910 x 1000|
|Ask||4.920 x 1500|
|Day's Range||4.910 - 5.060|
|52 Week Range||4.210 - 14.500|
|PE Ratio (TTM)||-3.16|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Endologix, Inc. (NASDAQ: ELGX ) announced Wednesday, 30-day results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) study. The data showed ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Endologix, Inc. Here are 5 ETFs with the largest exposure to ELGX-US. Comparing the performance and risk of Endologix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Endologix saw its shares hit a multiyear low following a meeting with the FDA concerning its Nellix Endovascular Aneurysm Sealing System.